4D Molecular Therapeutics Inc banner

4D Molecular Therapeutics Inc
NASDAQ:FDMT

Watchlist Manager
4D Molecular Therapeutics Inc Logo
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Watchlist
Price: 9.87 USD 6.02% Market Closed
Market Cap: $503.5m

Wall Street
Price Targets

FDMT Price Targets Summary
4D Molecular Therapeutics Inc

Wall Street analysts forecast FDMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FDMT is 33.28 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

Lowest
Price Target
17.17 USD
74% Upside
Average
Price Target
33.28 USD
237% Upside
Highest
Price Target
47.25 USD
379% Upside
4D Molecular Therapeutics Inc Competitors:
Price Targets
CENT
Central Garden & Pet Co
35% Upside
MRVL
Marvell Technology Group Ltd
13% Upside
ACIU
AC Immune SA
229% Upside
CDNA
CareDx Inc
44% Upside
APA
APA Corp (US)
-24% Downside

Revenue
Forecast

29% / Year
Past Growth
-25% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
29% / Year
Past Growth
-25% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 7 years the compound annual growth rate for 4D Molecular Therapeutics Inc's revenue is 29%. The projected CAGR for the next 3 years is -25%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FDMT's stock price target?
Price Target
33.28 USD

According to Wall Street analysts, the average 1-year price target for FDMT is 33.28 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

What is 4D Molecular Therapeutics Inc's Revenue forecast?
Projected CAGR
-25%

For the last 7 years the compound annual growth rate for 4D Molecular Therapeutics Inc's revenue is 29%. The projected CAGR for the next 3 years is -25%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett